While PD-L1 expression, tumor mutational burden (TMB), and circulating tumor DNA (ctDNA) have demonstrated potential, none possess sufficient predictive accuracy or standardization to warrant universal adoption across indications [22,23]. Here, CD274 is linked to neoplasm.